Nerviano Medical Sciences is part of NMS Group and it is focused on the discovery and early development of oncology drugs. Our business model is to partner our drugs at late preclinical or early clinical stage for full development and commercialization. 

Our mission is to pursue innovative therapeutic approaches in Oncology, discovering and developing molecules with novel mechanisms of action, for the advancement of personalized care of cancer patients. An experienced and lean management team leads a highly skilled staff of professionals with international experience and a broad range of expertise in R&D, combining the flexibility of a biotech with the quality standards of a big pharma.

Biotechnology

Life Sciences

Therapeutics

Nerviano Medical Sciences

Hugues Dolgos

Terrence West

Davide Martin Marchetti

Sidney Dung

Antonella Isacchi

Rosita Lupi

Alessia Montagnoli

The Research and Data Management team at Nerviano Medical Sciences is dedicated to supporting the discovery and early development of oncology drugs. This team integrates quality assurance, compound management, omics sciences, medicinal chemistry, and data management to ensure rigorous research processes and robust data analysis. By leveraging their diverse expertise, they aim to optimize the identification and development of novel cancer therapeutics.

Research and Data Management

Leadership Team

Research and Data Management

About

Team members

Other teams at Nerviano Medical Sciences

Leadership Team